共 18 条
[1]
Treatment of acute schizophrenia with paliperidone ER: Predictors for treatment response and benzodiazepine use.[J].Stephan Heres;Liana Don;Miroslav Herceg;Leszek Bidzan;Michel Blanc;Alberto Siracusano;Valentinas Maciulis;Marjolein Lahaye;Andreas Schreiner.Progress in Neuropsychopharmacology & Biological Psychiatry.2014,
[2]
Effectiveness of long-acting injectable risperidone versus oral antipsychotics in the treatment of recent-onset schizophrenia: a case–control study.[J].Pablo Barrio;Albert Batalla;Pere Castellví;Diego Hidalgo;Marta García;Ana Ortiz;Iria Grande;Alexandre Pons;Eduard Parellada.International Clinical Psychopharmacology.2013, 4
[3]
Rates and predictors of remission in first-episode schizophrenia within 1<ce:hsp sp="0.25"/>year of antipsychotic maintenance treatment. Results of a randomized controlled trial within the German Research Network on Schizophrenia.[J].Wolfgang Gaebel;Mathias Riesbeck;Wolfgang Wölwer;Ansgar Klimke;Matthias Eickhoff;Martina von Wilmsdorff;Isabella Heuser;Wolfgang Maier;Joachim Klosterkötter;Peter Falkai;Ralf Schlösser;Andrea Schmitt;Michael Riedel;Stefan Klingberg;Wolfgang Köpcke;Christian Ohmann;H
[4]
Plasma levels of mature brain-derived neurotrophic factor (BDNF) and matrix metalloproteinase-9 (MMP-9) in treatment-resistant schizophrenia treated with clozapine.[J].Hidenaga Yamamori;Ryota Hashimoto;Tamaki Ishima;Fukuko Kishi;Yuka Yasuda;Kazutaka Ohi;Michiko Fujimoto;Satomi Umeda-Yano;Akira Ito;Kenji Hashimoto;Masatoshi Takeda.Neuroscience Letters.2013,
[5]
[6]
[7]
[8]
[9]
[10]

